Hosted on MSN28m
Neurizon's fast-track application for flagship drug in Europe received 'positively'
While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...
Donald Trump and RFK Jr want to ‘Make America Healthy Again’. Where does that leave Europe?
New medicines, access to treatments, infectious disease monitoring, and more are on the table. View on euronews ...
Johnson & Johnson submits applications for new indications for Darzalex
Johnson & Johnson announced the submission of regulatory applications to the U.S. FDA and European Medicines Agency seeking approval of a ...
precisionmedicineonline2d
Rocket Pharma Starts Rolling BLA Submission for Fanconi Anemia Gene Therapy
RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.
FiercePharma2d
J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Healthline3d
Is Botox Safe If You Have Lupus?
For those with lupus, Botox has a heightened risk of side effects. It can also interact with your lupus medications, so it's best to discuss with your doctor first.
labiotech3d
Cystic fibrosis: Five biotechs breathing life into the therapeutic space
In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...
BeiGene: TEVIMBRA European Push Continues With Positive CHMP Opinion
BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...